{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:28:52Z","timestamp":1779910132082,"version":"3.53.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,6,28]],"date-time":"2014-06-28T00:00:00Z","timestamp":1403913600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/2046-4053-3-71","type":"journal-article","created":{"date-parts":[[2014,6,28]],"date-time":"2014-06-28T21:01:20Z","timestamp":1403989280000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Efficacy of turmeric in the treatment of digestive disorders: a systematic review and meta-analysis protocol"],"prefix":"10.1186","volume":"3","author":[{"given":"Kednapa","family":"Thavorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad M","family":"Mamdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon E","family":"Straus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,28]]},"reference":[{"key":"238_CR1","unstructured":"Digestive Diseases Statistics for the United States. [\n                    http:\/\/digestive.niddk.nih.gov\/statistics\/statistics.aspx\n                    \n                  ]"},{"key":"238_CR2","unstructured":"National Digestive Disorders Prevalence & Impact Study Report, Establishing Digestive Health as a National Priority. [\n                    http:\/\/www.cdhf.ca\/bank\/document_en\/25establishing-digestive-health-as-a-priority-for-canadians.pdf\n                    \n                  ]"},{"key":"238_CR3","volume-title":"Costs of Digestive Diseases","author":"C Ruhl","year":"2009","unstructured":"Ruhl C, Sayer B, Byrd-Holt D, Brown D: The burden of digestive diseases in the United States. Costs of Digestive Diseases. Edited by: Everhart JE. 2009, Bethesda: The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)"},{"key":"238_CR4","volume-title":"Gastroenterology in the UK: the Burden of Disease","author":"G Lewison","year":"1997","unstructured":"Lewison G: Gastroenterology in the UK: the Burden of Disease. 1997, London: The Wellcome Trust"},{"key":"238_CR5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1136\/gut.2005.078089","volume":"55","author":"K Tillisch","year":"2006","unstructured":"Tillisch K: Complementary and alternative medicine for functional gastrointestinal disorders. Gut. 2006, 55: 593-596. 10.1136\/gut.2005.078089.","journal-title":"Gut"},{"key":"238_CR6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S0210-5705(03)70453-1","volume":"27","author":"F Devesa Jorda","year":"2004","unstructured":"Devesa Jorda F, Pellicer Bataller J, Ferrando Ginestar J, Borghol Hariri A, Bustamante Balen M, Ortuno Cortes J, Ferrando Marrades I, Llobera Bertran C, Sala Lajo A, Minana Morell M, Nolasco Bonmat\u00ed A, Fresquet Febrer JL: Consumption of medicinal herbs in patients attending a gastroenterology outpatient clinic. Gastroenterol Hepatol. 2004, 27: 244-249. 10.1016\/S0210-5705(03)70453-1.","journal-title":"Gastroenterol Hepatol"},{"key":"238_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-2006-960004","volume":"57","author":"HP Ammon","year":"1991","unstructured":"Ammon HP, Wahl MA: Pharmacology of Curcuma longa. Planta Med. 1991, 57: 1-7. 10.1055\/s-2006-960004.","journal-title":"Planta Med"},{"key":"238_CR8","first-page":"141","volume":"14","author":"JS Jurenka","year":"2009","unstructured":"Jurenka JS: Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev. 2009, 14: 141-153.","journal-title":"Altern Med Rev"},{"key":"238_CR9","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/0006-2952(76)90421-4","volume":"25","author":"OP Sharma","year":"1976","unstructured":"Sharma OP: Antioxidant activity of curcumin and related compounds. Biochem Pharmacol. 1976, 25: 1811-1812. 10.1016\/0006-2952(76)90421-4.","journal-title":"Biochem Pharmacol"},{"key":"238_CR10","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1021\/jf990308d","volume":"47","author":"PS Negi","year":"1999","unstructured":"Negi PS, Jayaprakasha GK, Jagan Mohan Rao L, Sakariah KK: Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture. J Agric Food Chem. 1999, 47: 4297-4300. 10.1021\/jf990308d.","journal-title":"J Agric Food Chem"},{"key":"238_CR11","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0006-2952(99)00206-3","volume":"58","author":"BH Shah","year":"1999","unstructured":"Shah BH, Nawaz Z, Pertani SA, Roomi A, Mahmood H, Saeed SA, Gilani AH: Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling. Biochem Pharmacol. 1999, 58: 1167-1172. 10.1016\/S0006-2952(99)00206-3.","journal-title":"Biochem Pharmacol"},{"key":"238_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.canlet.2008.03.025","volume":"267","author":"P Anand","year":"2008","unstructured":"Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB: Curcumin and cancer: an \"old-age\" disease with an \"age-old\" solution. Cancer Lett. 2008, 267: 133-164. 10.1016\/j.canlet.2008.03.025.","journal-title":"Cancer Lett"},{"key":"238_CR13","volume-title":"Principles and Practice of Phytotherapy","author":"S Mills","year":"2000","unstructured":"Mills S, Bone K: Principles and Practice of Phytotherapy. 2000, London: Churchill Livingstone"},{"key":"238_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0378-8741(90)90094-A","volume":"29","author":"S Rafatullah","year":"1990","unstructured":"Rafatullah S, Tariq M, Al-Yahya MA, Mossa JS, Ageel AM: Evaluation of turmeric (Curcuma longa) for gastric and duodenal antiulcer activity in rats. J Ethnopharmacol. 1990, 29: 25-34. 10.1016\/0378-8741(90)90094-A.","journal-title":"J Ethnopharmacol"},{"key":"238_CR15","first-page":"613","volume":"72","author":"V Thamlikitkul","year":"1989","unstructured":"Thamlikitkul V, Bunyapraphatsara N, Dechatiwongse T, Theerapong S, Chantrakul C, Thanaveerasuwan T, Nimitnon S, Boonroj P, Punkrut W, Gingsungneon V, Wongkonkatape S, Ekpalakorn W, Boontaeng N, Jesadaporn U, Taechaiya S, Petcharoen S, Riewpaiboon A, Adthasit R, Timsard S, Tenambergen ED: Randomized double blind study of Curcuma domestica Val. for dyspepsia. J Med Assoc Thai. 1989, 72: 613-620.","journal-title":"J Med Assoc Thai"},{"key":"238_CR16","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.cgh.2006.08.008","volume":"4","author":"H Hanai","year":"2006","unstructured":"Hanai H, Iida T, Takeuchi K, Watanabe F, Maruyama Y, Andoh A, Tsujikawa T, Fujiyama Y, Mitsuyama K, Sata M, Yamada M, Iwaoka Y, Kanke K, Hiraishi H, Hirayama K, Arai H, Yoshii S, Uchijima M, Nagata T, Koide Y: Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol. 2006, 4: 1502-1506. 10.1016\/j.cgh.2006.08.008.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"238_CR17","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1080\/00365520510023134","volume":"40","author":"B Brinkhaus","year":"2005","unstructured":"Brinkhaus B, Hentschel C, Von Keudell C, Schindler G, Lindner M, Stutzer H, Kohnen R, Willich SN, Lehmacher W, Hahn EG: Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome: a randomized, placebo-controlled, double-blind clinical trial. Scand J Gastroenterol. 2005, 40: 936-943. 10.1080\/00365520510023134.","journal-title":"Scand J Gastroenterol"},{"key":"238_CR18","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jclinepi.2008.10.009","volume":"62","author":"BJ Shea","year":"2009","unstructured":"Shea BJ, Hamel C, Wells GA, Bouter LM, Kristjansson E, Grimshaw J, Henry DA, Boers M: AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J Clin Epidemiol. 2009, 62: 1013-1020. 10.1016\/j.jclinepi.2008.10.009.","journal-title":"J Clin Epidemiol"},{"key":"238_CR19","first-page":"Cd008424","volume":"10","author":"S Kumar","year":"2012","unstructured":"Kumar S, Ahuja V, Sankar MJ, Kumar A, Moss AC: Curcumin for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev. 2012, 10: Cd008424-","journal-title":"Cochrane Database Syst Rev"},{"key":"238_CR20","unstructured":"Preferred Reporting Items for Systematic reviews and Meta-Analyses for Protocols (PRISMA-P). [\n                    http:\/\/2013.colloquium.cochrane.org\/abstracts\/preferred-reporting-items-systematic-reviews-and-meta-analyses-protocols-prisma-p-2013\n                    \n                  ]"},{"key":"238_CR21","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1053\/j.gastro.2004.05.030","volume":"127","author":"J Tack","year":"2004","unstructured":"Tack J, Bisschops R, Sarnelli G: Pathophysiology and treatment of functional dyspepsia. Gastroenterology. 2004, 127: 1239-1255. 10.1053\/j.gastro.2004.05.030.","journal-title":"Gastroenterology"},{"key":"238_CR22","volume-title":"Protocol for diagnosis and treatment of peptic ulcer in adults","author":"American International Health Alliance","year":"2002","unstructured":"American International Health Alliance: Protocol for diagnosis and treatment of peptic ulcer in adults. 2002, Washington: American International Health Alliance"},{"key":"238_CR23","unstructured":"Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders. [\n                    http:\/\/www.romecriteria.org\/assets\/pdf\/19_RomeIII_apA_885-898.pdf\n                    \n                  ]"},{"key":"238_CR24","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1572-0241.2005.41217.x","volume":"100","author":"KR DeVault","year":"2005","unstructured":"DeVault KR, Castell DO: Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005, 100: 190-200. 10.1111\/j.1572-0241.2005.41217.x.","journal-title":"Am J Gastroenterol"},{"key":"238_CR25","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/MEG.0b013e328317b89e","volume":"21","author":"KA Gwee","year":"2009","unstructured":"Gwee KA, Teng L, Wong RK, Ho KY, Sutedja DS, Yeoh KG: The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 2009, 21: 417-424. 10.1097\/MEG.0b013e328317b89e.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"238_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1046\/j.1365-2036.11.s1.15.x","volume":"11","author":"SJ Veldhuyzen van Zanten","year":"1997","unstructured":"Veldhuyzen van Zanten SJ: The role of Helicobacter pylori infection in non-ulcer dyspepsia. Aliment Pharmacol Ther. 1997, 11 (Suppl 1): 63-69.","journal-title":"Aliment Pharmacol Ther"},{"key":"238_CR27","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S1542-3565(04)00348-9","volume":"2","author":"DA Revicki","year":"2004","unstructured":"Revicki DA, Rentz AM, Tack J, Stanghellini V, Talley NJ, Kahrilas P, De La Loge C, Trudeau E, Dubois D: Responsiveness and interpretation of a symptom severity index specific to upper gastrointestinal disorders. Clin Gastroenterol Hepatol. 2004, 2: 769-777. 10.1016\/S1542-3565(04)00348-9.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"238_CR28","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1440-1746.1992.tb01489.x","volume":"7","author":"P Bamberg","year":"1992","unstructured":"Bamberg P, Caswell CM, Frame MH, Lam SK, Wong EC: A meta-analysis comparing the efficacy of omeprazole with H2-receptor antagonists for acute treatment of duodenal ulcer in Asian patients. J Gastroenterol Hepatol. 1992, 7: 577-585. 10.1111\/j.1440-1746.1992.tb01489.x.","journal-title":"J Gastroenterol Hepatol"},{"key":"238_CR29","first-page":"19","volume":"6","author":"M Romano","year":"2004","unstructured":"Romano M, Cuomo A: Eradication of Helicobacter pylori: a clinical update. Med Gen Med. 2004, 6: 19-","journal-title":"Med Gen Med"},{"key":"238_CR30","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1136\/gut.48.2.272","volume":"48","author":"R Akehurst","year":"2001","unstructured":"Akehurst R, Kaltenthaler E: Treatment of irritable bowel syndrome: a review of randomised controlled trials. Gut. 2001, 48: 272-282. 10.1136\/gut.48.2.272.","journal-title":"Gut"},{"key":"238_CR31","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1007\/BF02064187","volume":"40","author":"DA Drossman","year":"1995","unstructured":"Drossman DA, Li Z, Toner BB, Diamant NE, Creed FH, Thompson D, Read NW, Babbs C, Barreiro M, Bank L, Whitehead WE, Schuster MM, Guthrie EA: Functional bowel disorders: a multicenter comparison of health status and development of illness severity index. Dig Dis Sci. 1995, 40: 986-995. 10.1007\/BF02064187.","journal-title":"Dig Dis Sci"},{"key":"238_CR32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","volume":"11","author":"CY Francis","year":"1997","unstructured":"Francis CY, Morris J, Whorwell PJ: The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997, 11: 395-402. 10.1046\/j.1365-2036.1997.142318000.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 2","key":"238_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1046\/j.1365-2036.17.s2.17.x","volume":"17","author":"R Sostegni","year":"2003","unstructured":"Sostegni R, Daperno M, Scaglione N, Lavagna A, Rocca R, Pera A: Review article: Crohn's disease: monitoring disease activity. Aliment Pharmacol Ther. 2003, 17 (Suppl 2): 11-17.","journal-title":"Aliment Pharmacol Ther"},{"key":"238_CR34","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1056\/NEJMoa050516","volume":"353","author":"P Rutgeerts","year":"2005","unstructured":"Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, Travers S, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF: Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005, 353: 2462-2476. 10.1056\/NEJMoa050516.","journal-title":"N Engl J Med"},{"key":"238_CR35","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ajg.2009.83","volume":"104","author":"EJ Scherl","year":"2009","unstructured":"Scherl EJ, Pruitt R, Gordon GL, Lamet M, Shaw A, Huang S, Mareya S, Forbes WP: Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study. Am J Gastroenterol. 2009, 104: 1452-1459. 10.1038\/ajg.2009.83.","journal-title":"Am J Gastroenterol"},{"key":"238_CR36","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1046\/j.1442-2050.2000.00129.x","volume":"13","author":"CJ Allen","year":"2000","unstructured":"Allen CJ, Parameswaran K, Belda J, Anvari M: Reproducibility, validity, and responsiveness of a disease-specific symptom questionnaire for gastroesophageal reflux disease. Dis Esophagus. 2000, 13: 265-270. 10.1046\/j.1442-2050.2000.00129.x.","journal-title":"Dis Esophagus"},{"key":"238_CR37","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0197-2456(94)90031-0","volume":"15","author":"WO Williford","year":"1994","unstructured":"Williford WO, Krol WF, Spechler SJ: Development for and results of the use of a gastroesophageal reflux disease activity index as an outcome variable in a clinical trial: VA Cooperative Study Group on Gastroesophageal Reflux Disease (GERD). Control Clin Trials. 1994, 15: 335-348. 10.1016\/0197-2456(94)90031-0.","journal-title":"Control Clin Trials"},{"key":"238_CR38","unstructured":"Suggested risk of bias criteria for EPOC reviews. [\n                    http:\/\/epoc.cochrane.org\/sites\/epoc.cochrane.org\/files\/uploads\/14%20Suggested%20risk%20of%20bias%20criteria%20for%20EPOC%20reviews%202013%2008%2012.pdf\n                    \n                  ]"},{"key":"238_CR39","unstructured":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. [\n                    http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp\n                    \n                  ]"},{"key":"238_CR40","first-page":"317","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"J Sterne","year":"2008","unstructured":"Sterne J, Egger M, Moher D: Addressing reporting biases. Cochrane Handbook for Systematic Reviews of Interventions. Edited by: Higgins J, Green S. 2008, England: John Wiley & Sons Ltd, 317-"},{"key":"238_CR41","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/jcb.240630706","volume":"63","author":"Chemoprevention Branch and Agent Development Committee","year":"1996","unstructured":"Chemoprevention Branch and Agent Development Committee: Clinical development plan: Curcumin. J Cell Biochem. 1996, 63: 72-85.","journal-title":"J Cell Biochem"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2046-4053-3-71.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2046-4053-3-71\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2046-4053-3-71","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2046-4053-3-71.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T20:41:56Z","timestamp":1548189716000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/2046-4053-3-71"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,28]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["238"],"URL":"https:\/\/doi.org\/10.1186\/2046-4053-3-71","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,28]]},"assertion":[{"value":"19 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"71"}}